ILYANG PHARMACEUTICAL CO.,LTD Logo

ILYANG PHARMACEUTICAL CO.,LTD

Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.

007570 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 하갈로 110, 용인시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Founded in 1946, Ilyang Pharmaceutical is a research-driven company focused on the development and manufacturing of pharmaceutical products. The company's portfolio includes a wide range of prescription drugs, over-the-counter medications, vaccines, and health supplements. It has developed key products in therapeutic areas such as oncology, gastroenterology, and circulatory system disorders. Notable developments include Supect®, a new chemical entity for the treatment of leukemia, and Noltec®, an anti-ulcer agent. Ilyang emphasizes high-quality production through advanced manufacturing facilities and a commitment to innovation in addressing global health needs.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ILYANG PHARMACEUTICAL CO.,LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-11 00:00
Legal Proceedings Report
회계처리기준위반에따른검찰고발등조치
Korean 7.0 KB
2025-09-11 00:00
Legal Proceedings Report
기타시장안내 (상장적격성 실질심사 사유 발생)
Korean 4.9 KB
2025-09-11 00:00
Legal Proceedings Report
[기재정정]기타시장안내 (상장적격성 실질심사 사유 발생)
Korean 8.2 KB
2025-09-10 00:00
Regulatory News Service
매매거래정지및정지해제(풍문등조회공시)
Korean 5.1 KB
2025-09-10 00:00
Legal Proceedings Report
조회공시요구(풍문또는보도)
Korean 3.5 KB

Automate Your Workflow. Get a real-time feed of all ILYANG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ILYANG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea 293480
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea 128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden HNSA
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan 4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan 219A
HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea 376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland HRTIS

Talk to a Data Expert

Have a question? We'll get back to you promptly.